Tylenol PM Should Be Avoided in Patients with Narrow-Angle Glaucoma
Tylenol PM (acetaminophen/diphenhydramine) is contraindicated in patients with glaucoma according to the FDA drug label, and should be avoided particularly in those with narrow-angle (angle-closure) glaucoma due to the anticholinergic effects of diphenhydramine. 1
Why Diphenhydramine Is Problematic
The diphenhydramine component of Tylenol PM poses the primary risk. Anticholinergic drugs like diphenhydramine can precipitate acute angle-closure attacks by causing pupillary dilation and angle narrowing 2. The American Academy of Ophthalmology's Primary Angle Closure guidelines specifically warn that "topical, inhaled, or oral drugs with adrenergic or anticholinergic effects...may induce angle narrowing and potentially precipitate an angle-closure attack" 2.
This mechanism is well-established:
- Anticholinergic agents inhibit the pupillary sphincter muscle
- This leads to mid-pupillary dilation
- The dilated iris bunches up peripherally, blocking the drainage angle
- Aqueous humor cannot exit the eye, causing dangerous IOP spikes
Multiple studies confirm anticholinergics (including antihistamines like diphenhydramine) as precipitants of acute angle-closure 3, 4, 5. A large Korean database study of 13,531 patients identified 61 drugs associated with acute angle-closure, with anticholinergic medications prominently featured 5.
What About the Acetaminophen Component?
Interestingly, acetaminophen alone appears safe and may even lower IOP in open-angle glaucoma through cannabinoid receptor mechanisms 6, 7. However, this does not mitigate the risk from diphenhydramine in the combination product.
Type of Glaucoma Matters Critically
- Narrow-angle (angle-closure) glaucoma: Absolute contraindication due to risk of acute attack
- Open-angle glaucoma: Lower risk, but anticholinergics should still be used cautiously as they may be inappropriately prescribed in this population 8
- Post-iridotomy patients: Even patients with previous successful peripheral iridotomies can experience acute angle-closure when exposed to anticholinergics, as demonstrated in a case report involving a decongestant 9
Clinical Pitfalls to Avoid
- Don't assume all glaucoma is the same: The FDA label states "ask a doctor before use if you have glaucoma" 1 but doesn't specify type—narrow-angle glaucoma carries much higher risk
- Don't overlook over-the-counter medications: Patients often don't report OTC sleep aids to their ophthalmologist
- Don't forget about combination products: Many cold/flu medications contain both decongestants AND antihistamines, compounding risk
Safer Alternatives for Sleep
For patients with glaucoma needing sleep assistance:
- Acetaminophen alone (without diphenhydramine) for pain-related insomnia
- Melatonin
- Non-anticholinergic sleep aids (consult with prescriber)
- Address underlying sleep hygiene issues
Bottom Line Algorithm
If narrow-angle glaucoma or angle-closure suspect → Do NOT use Tylenol PM
If open-angle glaucoma → Use with extreme caution only after ophthalmology consultation
If glaucoma type unknown → Assume narrow-angle until proven otherwise; avoid Tylenol PM
The risk of precipitating an acute angle-closure attack—which can cause permanent vision loss within hours—far outweighs any benefit from this over-the-counter sleep aid 2.